Sector Alpha Week of 2026-08-05
Sector Alpha — machine-written from the numbers · Data as of 2026-08-05

Uranium Royalty Corp.

UROY
Energy · Uranium

Uranium Royalty Corp.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.

The sharpest disagreement: the price moved +33.5% in a year while annual EPS moved −150.0% — the difference is re-rating, and re-rating has to be repaid with earnings.

The price is between stages. Underneath, the last four quarters read mixed. What settles it: whether earnings grow into a price that has already moved.

Price
$3.4
+33.5% 1Y
P/E
11.6×
of its own 1-year range
Revenue (Jan 26)
$0.0 B
Profit (Jan 26)
$0.0 B
Operating margin
0.0%
ROE
15%
FY25
ROIC
31.4%
vs WACC 13.9% → +17.5 pp
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

Uranium Royalty Corp. trades at $3.4, between stages. That is −9.5% against its own 200-day average. It sits at 31% of a 52-week range of $3 to $5. On relative strength it is currently behind the S&P 500 on a trailing-13-week view (21 weeks and counting).

Today the stock is between stages. At $3.4 it trades −9.5% versus its 200-day average and sits at 31% of its 52-week range ($3–$5).

Aug 26: $3.4 Weekly closing price ($) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 1-year window.
−9.5% versus the 200-day line, week — of stage —
Price50-day avg200-day avg
$5.1$4.3$3.6$2.9$2.2$$3$4Jul 25Oct 25Jan 26May 26Aug 26
$5.1$4.3$3.6$2.9$2.2$$3$4Jul 25Jan 26Aug 26
Beating or trailing, week by week since 2025 Each cell is one week from 2025 to now (57 weeks): the stock's trailing 13-week return minus the S&P 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the S&P 500 reading is not held.
trailing 13-week return vs the S&P 500
Jul 25Aug 26

Against the market, two honest reads. Cumulative: over the last 1.1 years the stock moved +41% while the S&P 500 moved +24% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (21 weeks and counting; last ahead the week of 2026-03-13) — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.

Uranium Royalty Corp. trades at 11.6× P/E, against too little history to rank. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 11.6× is against too little history to rank. This is a comparison against the stock's own history — not a claim about what it is worth.

P/E 11.6× vs a null× long-run median P/E, weekly (left axis); earnings per share, trailing twelve months, weekly step line (right axis). 1.1-year window; loss-period spikes above 231× shown pinned at the top. The eps (ttm) bars are red where the reading is lower than the quarter before.
against too little history to rank
P/EEPS (TTM) (quarterly)
244.0×$0.04196.9×$0.03149.9×$0.02102.8×$0.0155.8×$0.00×$83.75×$0Jul 25Oct 25Jan 26May 26Aug 26
244.0×$0.04196.9×$0.03149.9×$0.02102.8×$0.0155.8×$0.00×$83.75×$0Jul 25Jan 26Aug 26
P/E
11.6×
too little history to rank
PEG
n/m
not derivable — 3-year earnings growth unavailable

🚨 Why the multiple sits where it does: over the past year annual EPS moved −150.0% against a +33.5% price move — the price outran earnings, pushing the multiple UP its own range.

Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.

03 · Stage: No read

Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

Uranium Royalty Corp. reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 7 quarters across 1 curve, on partial evidence.

Growth, year by year: revenue −50.0% in FY25, profit −200.0% Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn.
Revenue YoYProfit YoYEPS YoY
328%−146%227%−161%125%−175%24%−190%−78%−204%%%−50%−200%FY23FY24FY25
328%−146%227%−161%125%−175%24%−190%−78%−204%%%−50%−200%FY23FY24FY25
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. Where the trailing-twelve-month history is short, the curve falls back to single-quarter year-on-year growth — noisier, and the classifier smooths and caps base-effect spikes before reading. A missing point means that reading is not held for the quarter.
the trajectory the stage is read from
RevenueProfitEPS
8.0%−28%−21%−47%−50%−67%−79%−86%−108%−105%%%−100%−100%−33.3%Apr 23Oct 24Jan 26
8.0%−28%−21%−47%−50%−67%−79%−86%−108%−105%%%−100%−100%−33.3%Apr 23Oct 24Jan 26
ROCE Trailing-twelve-month operating profit (before interest and tax) as a share of average capital employed — total assets minus current liabilities, the standard textbook basis, %.
the return curve, computed quarterly
ROCE
1.2%0.6%0.0%−0.6%−1.2%%0%Apr 23Jan 24Oct 24Apr 25Jan 26
1.2%0.6%0.0%−0.6%−1.2%%0%Apr 23Oct 24Jan 26
ROCE
Stuck low
latest 0.0% · span 0.0%–0.0%

Why it matters: with too little history, an honest page says so instead of guessing a trajectory.

Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; stock price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue−50.0%
Stock price+33.5%
04 · 4-Factor Sector Score

4-Factor Sector Score

62.5/100 — rank 8 of 13 in Uranium · 50% evidence confidence · provisional, ranked below fully-evidenced peers

Uranium Royalty Corp. scores 62.5 out of 100 against the 13 companies it is compared with in Uranium, ranking 8. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

The four contributions add to the total exactly: 22.5 + 17.3 + 11.1 + 11.6 = 62.5. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

05 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

Uranium Royalty Corp. reported $0.0 B of revenue in the Jan 26 quarter. Over 2 years it has compounded at 41.4% a year. The last full year, FY25, came in at $0.0 B. The last four reported quarters add to $0.1 B.

FY25 revenue came in at $0.0 B (−50.0% on the year), capping 2 years at 41.4% compound. The latest quarter (Jan 26) printed $0.0 B, null year on year.

FY25 revenue $0.0 B (−50.0% YoY) Revenue bars, $ B (left); YoY growth-% line (right). 3-year window. A bar is red when it is lower than the year before.
41.4% a year over 2 years
RevenueYoY growth
0.04328%0.03227%0.02125%0.0124%0.00−78%$ B%$0B−50%FY23FY24FY25
0.04328%0.03227%0.02125%0.0124%0.00−78%$ B%$0B−50%FY23FY24FY25
Jan 26: $0.0 B (null YoY) Quarterly revenue bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Revenue (quarterly)YoY growth
0.0328.0%0.024−21%0.016−50%0.008−79%0.000−108%$ B%$0B−100%Apr 23Oct 24Jan 26
0.0328.0%0.024−21%0.016−50%0.008−79%0.000−108%$ B%$0B−100%Apr 23Oct 24Jan 26

Pace check: the last four quarters averaged −100.0% growth against the decade's 41.4% — the current year is running slower than its own long-run rate.

06 · Operating margin

Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

Uranium Royalty Corp.'s operating margin is 0.0% in the Jan 26 quarter. Across 3 fiscal years the operating margin has ranged 0.0% to 25.0%. The current quarter sits inside that band.

The latest quarter's operating margin is 0.0%, null pp against the same quarter a year ago. Across 3 fiscal years the operating margin has ranged 0.0%–25.0%.

Why the margin moved: operating margin went +0.0 pp year on year while gross margin went −50.0 pp — the gain came mostly from the gross line: input costs and pricing.

FY25: 0.0% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 3-year window.
within a 0.0–25.0% band over 3 years
operating marginYoY change (pp)
27%29%20%15%13%0.0%5.3%−15%−2.0%−29%%%0%−25%FY23FY24FY25
27%29%20%15%13%0.0%5.3%−15%−2.0%−29%%%0%−25%FY23FY24FY25
Jan 26: 0.0% operating margin (null pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
1.2%1.2%0.6%0.6%0.0%0.0%−0.6%−0.6%−1.2%−1.2%%%0%0%Apr 23Oct 24Jan 26
1.2%1.2%0.6%0.6%0.0%0.0%−0.6%−0.6%−1.2%−1.2%%%0%0%Apr 23Oct 24Jan 26
07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

Uranium Royalty Corp. earned $0.0 B of net profit in the Jan 26 quarter. The full FY25 year was a loss of $0.01 B. That is 0.0% of the quarter's revenue. The same quarter a year earlier earned $0.0 B.

Jan 26 profit was $0.0 B, null year on year. On the full year, FY25 printed $−0.0 B (−200.0%).

FY25 profit $−0.0 B (−200.0% YoY) Net profit bars, $ B (left); YoY growth-% line (right). 3-year window. A bar is red when it is lower than the year before.
Net profitYoY growth
0.012−198.8%0.006−199.4%0.000−200.0%−0.006−200.6%−0.012−201.2%$ B%$0B−200%FY23FY24FY25
0.012−198.8%0.006−199.4%0.000−200.0%−0.006−200.6%−0.012−201.2%$ B%$0B−200%FY23FY24FY25
Jan 26: $0.0 B (null YoY) Quarterly net profit bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Net profit (quarterly)YoY growth
0.011−98.8%0.008−99.4%0.005−100.0%0.003−100.6%0.000−101.2%$ B%$0B−100%Apr 23Oct 24Jan 26
0.011−98.8%0.008−99.4%0.005−100.0%0.003−100.6%0.000−101.2%$ B%$0B−100%Apr 23Oct 24Jan 26
08 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Uranium Royalty Corp.'s cash-flow history is too thin to judge how much reported profit converts into cash. In FY25 that was $−0.0 B of operating cash against $−0.0 B of profit. Cash resolution here is annual, because quarterly cash statements are not published.

FY25: operating cash of $−0.0 B against reported profit of $−0.0 B.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

FY25: CFO $−0.0 B vs profit $−0.0 B Operating cash flow and net profit by fiscal year, $ B; the line is free cash flow (CFO minus capital spending). 3-year window, annual resolution.
Operating cashNet profit
0.02−0.01−0.03−0.06−0.09$ B$0B$0BFY23FY24FY25
0.02−0.01−0.03−0.06−0.09$ B$0B$0BFY23FY24FY25
Apr 26: operating cash $0.1 B Operating cash per quarter, $ B (bars); conversion = operating cash as % of net profit (line, right). Last 12 quarters. Dashed line = 100%.
Operating cash (quarterly)Conversion100%
0.17116%0.1158%0.050.0%−0.02−58%−0.08−116%$ B%$0B−100%Jul 23Oct 24Apr 26
0.17116%0.1158%0.050.0%−0.02−58%−0.08−116%$ B%$0B−100%Jul 23Oct 24Apr 26

Router verdict: no single sink dominates — the next section checks both the working-capital cycle and the capital spending.

09 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

Uranium Royalty Corp. does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Nothing is estimated in place of the missing day-counts, so no cash-cycle chart is drawn.

Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.

The synthesis: neither the cycle nor the build-out is hoarding the cash — the machine is reasonably clean.

10 · Return on equity

Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.

Uranium Royalty Corp. earns a ROE of −5% in FY25. That is up from a trough of −8% in FY23. Return on invested capital clears the cost of that capital by +17.5 percentage points, so growth here adds value rather than only size. The wiring behind it is −50.0% net margin on 0.10× asset turns.

FY25 ROE is −5%, recovered from a FY23 trough of −8% — the full ladder below shows the fall and the climb, undoctored.

Why the return is what it is — the wiring (FY25): −50.0% net margin × 0.10× asset turns × 1.00× balance-sheet leverage ≈ −5.0% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.

The capstone test — ROIC − WACC: 31.4% − 13.9% = a +17.5 pp spread. The 13.9% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. A spread this wide means every dollar reinvested creates more than a dollar of value — the engine compounds.

FY25: ROE −5% Return on equity by fiscal year, % (line); ROIC by fiscal year, % (line). 3-year window, dips included. Dashed line = the 13.9% cost of capital used on this page.
the climb back from FY23's −8%
ROEROIC (annual)WACC
16%9.4%3.1%−3.2%−9.4%%−4.8%−1.7%FY23FY24FY25
16%9.4%3.1%−3.2%−9.4%%−4.8%−1.7%FY23FY24FY25
Apr 26: ROIC 1.2% (TTM) vs WACC 13.9% Trailing-twelve-month ROIC and ROE, per quarter, %; dashed line = the cost of capital. Last 12 quarters, put on a trailing-twelve-month basis and anchored to the annual figure.
ROIC (TTM)ROE (TTM)WACC
18%9.3%0.7%−8.0%−17%%1.2%4.6%Jul 23Oct 24Apr 26
18%9.3%0.7%−8.0%−17%%1.2%4.6%Jul 23Oct 24Apr 26
11 · Dividend

Dividend

Uranium Royalty Corp. pays no dividend. Across the last 10 reported quarters it has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings rather than distribute them, which makes the cash-flow and reinvestment sections the place that cash shows up.

Uranium Royalty Corp. does not currently pay a dividend. Across the last 10 reported quarters the company has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings instead of distributing them.

12 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.

Uranium Royalty Corp. carries total debt of $0.0 B against shareholder equity of $0.3 B as of Apr 26, a debt-to-equity of 0.00 — effectively unlevered. On the annual view that ratio went from 0.00 in FY21 to 0.00 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.

Apr 26: total debt of $0.0 B against shareholder equity of $0.3 B — a debt-to-equity of 0.00. On the annual view, debt-to-equity went from 0.00 (FY21) to 0.00 (FY26). The returns on this page are earned, not borrowed.

FY26: debt $0.0 B at 0.00× equity Total debt by fiscal year, $ B (bars); debt-to-equity, × (line). 6-year window.
Total debtDebt-to-equity
0.0110.09×0.0080.06×0.0050.04×0.0030.02×0.000−0.01×$ B×$0B0.00×FY21FY23FY26
0.0110.09×0.0080.06×0.0050.04×0.0030.02×0.000−0.01×$ B×$0B0.00×FY21FY23FY26
Apr 26: debt $0.0 B, debt-to-equity 0.00 Total debt per quarter, $ B (bars); debt-to-equity, × (line). Last 12 quarters.
Total debt (quarterly)Debt-to-equity
0.0110.09×0.0080.06×0.0050.04×0.0030.02×0.000−0.01×$ B×$0B0.00×Jan 23Oct 24Apr 26
0.0110.09×0.0080.06×0.0050.04×0.0030.02×0.000−0.01×$ B×$0B0.00×Jan 23Oct 24Apr 26
13 · Ownership

Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.

0.9% of Uranium Royalty Corp.'s tradable float is currently sold short — the crowd is not positioned against this stock. At typical trading volumes those positions would take about 1.5 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.

The latest reading: 0.9% of the float is sold short, and at typical trading volumes it would take about 1.5 days to buy those positions back. The crowd is not positioned against this stock. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.

Short interest
0.9%
of the tradable float
Days to cover
1.5
at typical volumes

Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.

14 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

Uranium Royalty Corp.: the Z-score reads 6.68. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits well clear of distress. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.

Why it matters: a Z-score of 6.68 sits well clear of the distress zone — the balance sheet is not the risk here.

The safety line in one sentence: the Z-score reads 6.68.

15 · Related companies · Uranium
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Cameco CorporationCCJ 55.0/100Mixed-positive evidence81% evidence ASLEEP 19.8/35 Revenue 7.5% · PAT 100% · OPM change -4.1 pp 83% evidence 15.4/25 ROCE 1.8% · OPM 19.4% 76% evidence 5.2/20 P/E 101.3× · PEG 2.64 65% evidence 14.6/20 RS sector 8.5% · RS bench -15.8% · 1Y 21%0 of 12 weeks ahead 100% evidence
Exact sum: 19.8 + 15.4 + 5.2 + 14.6 = 55 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
2enCore Energy Corp.EU 51.8/100Thin evidence · provisional55% evidence BASING 24.5/35 Revenue 53.6% · PAT — · OPM change 140.1 pp 62% evidence 14.3/25 ROCE 3% · OPM 54.4% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 3.0/20 RS sector -40.7% · RS bench -54.6% · 1Y -56.9%0 of 12 weeks ahead 70% evidence
Exact sum: 24.5 + 14.3 + 10 + 3 = 51.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
3IsoEnergy Ltd.ISOU 48.8/100Thin evidence · provisional52% evidence ASLEEP 13.0/35 Revenue — · PAT -225% · OPM change — 57% evidence 11.8/25 ROCE -1.4% · OPM — 61% evidence 10.6/20 P/E 31.7× · PEG — 15% evidence 13.4/20 RS sector 9.6% · RS bench -14.6% · 1Y 31.6%1 of 12 weeks ahead 70% evidence
Exact sum: 13 + 11.8 + 10.6 + 13.4 = 48.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
4Energy Fuels Inc.UUUU 45.3/100Mixed-negative evidence64% evidence ASLEEP 23.0/35 Revenue 21.4% · PAT — · OPM change 107.8 pp 62% evidence 9.0/25 ROCE -1.7% · OPM -47.2% 76% evidence 11.5/20 P/E 11.6× · PEG — 15% evidence 1.8/20 RS sector -10.6% · RS bench -31.6% · 1Y 34.7%0 of 12 weeks ahead 100% evidence
Exact sum: 23 + 9 + 11.5 + 1.8 = 45.3 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -10.6% and the one-year return is 34.7%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
5Centrus Energy Corp.LEU 41.7/100Mixed-negative evidence81% evidence BASING 7.5/35 Revenue -4% · PAT -43% · OPM change -27 pp 83% evidence 13.0/25 ROCE 0.1% · OPM 1% 76% evidence 11.6/20 P/E 57.5× · PEG 1.26 65% evidence 9.6/20 RS sector -5.5% · RS bench -27.3% · 1Y -15.2%0 of 12 weeks ahead 100% evidence
Exact sum: 7.5 + 13 + 11.6 + 9.6 = 41.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
6Denison Mines Corp.DNN 40.6/100Thin evidence · provisional60% evidence ASLEEP 8.6/35 Revenue 0% · PAT — · OPM change -3004.9 pp 62% evidence 8.3/25 ROCE -3.5% · OPM — 61% evidence 9.8/20 P/E 45.7× · PEG — 15% evidence 13.9/20 RS sector 10.6% · RS bench -14.3% · 1Y 40.6%0 of 12 weeks ahead 100% evidence
Exact sum: 8.6 + 8.3 + 9.8 + 13.9 = 40.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
7Uranium Energy Corp.UEC 33.8/100Thin evidence · provisional53% evidence ASLEEP 14.2/35 Revenue — · PAT — · OPM change -109.3 pp 32% evidence 7.6/25 ROCE -3.2% · OPM -116.6% 76% evidence 8.5/20 P/E 595× · PEG — 15% evidence 3.5/20 RS sector -6.6% · RS bench -28.1% · 1Y 3.1%0 of 12 weeks ahead 100% evidence
Exact sum: 14.2 + 7.6 + 8.5 + 3.5 = 33.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
8Uranium Royalty Corp.this pageUROY 62.5/100Thin evidence · provisional50% evidence ASLEEP 22.5/35 Revenue — · PAT — · OPM change 43717.6 pp 39% evidence 17.3/25 ROCE 15.9% · OPM 17.6% 76% evidence 11.1/20 P/E 14.2× · PEG — 15% evidence 11.6/20 RS sector 6.8% · RS bench -17.4% · 1Y 27.9%0 of 12 weeks ahead 70% evidence
Exact sum: 22.5 + 17.3 + 11.1 + 11.6 = 62.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
9NexGen Energy Ltd.NXE 53.8/100Thin evidence · provisional50% evidence ASLEEP 16.4/35 Revenue — · PAT — · OPM change — 33% evidence 10.7/25 ROCE -1.5% · OPM — 61% evidence 10.2/20 P/E 40.2× · PEG — 15% evidence 16.5/20 RS sector 12.1% · RS bench -13% · 1Y 41.9%0 of 12 weeks ahead 100% evidence
Exact sum: 16.4 + 10.7 + 10.2 + 16.5 = 53.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
10Deep Fission, Inc.FISN 46.4/100Thin evidence · provisional27% evidence 20.1/35 Revenue — · PAT — · OPM change — 33% evidence 6.3/25 ROCE -47% · OPM — 61% evidence 10.0/20 P/E — · PEG — 0% evidence 10.0/20 RS sector — · RS bench — · 1Y — 0% evidence
Exact sum: 20.1 + 6.3 + 10 + 10 = 46.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
11Nuclea Energy Inc.NCLA 44.9/100Thin evidence · provisional11% evidence 17.5/35 Revenue — · PAT — · OPM change — 0% evidence 7.4/25 ROCE -58.4% · OPM — 46% evidence 10.0/20 P/E — · PEG — 0% evidence 10.0/20 RS sector — · RS bench — · 1Y — 0% evidence
Exact sum: 17.5 + 7.4 + 10 + 10 = 44.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
12Ur-Energy Inc.URG 39.6/100Thin evidence · provisional47% evidence ASLEEP 15.6/35 Revenue — · PAT — · OPM change -68.1 pp 39% evidence 5.1/25 ROCE -9.7% · OPM -517.2% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 8.9/20 RS sector -0.6% · RS bench -23% · 1Y 6.6%0 of 12 weeks ahead 70% evidence
Exact sum: 15.6 + 5.1 + 10 + 8.9 = 39.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
13Eagle Nuclear Energy Corp.NUCL 34.3/100Thin evidence · provisional34% evidence ASLEEP 13.4/35 Revenue — · PAT — · OPM change — 24% evidence 7.0/25 ROCE -259.2% · OPM — 46% evidence 10.0/20 P/E — · PEG — 0% evidence 3.9/20 RS sector -25.6% · RS bench -42.3% · 1Y -43.6%6 of 12 weeks ahead 70% evidence
Exact sum: 13.4 + 7 + 10 + 3.9 = 34.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

16 · Frequently asked questions

Frequently asked questions

What is Uranium Royalty Corp.'s stock price today?

Uranium Royalty Corp. trades at $3.4, +33.5% over the past year. The company is valued at $1.0 B. The stock sits at 31% of its 52-week range of $3–$5, −9.5% versus its 200-day average. Against the S&P 500 it has been behind on a trailing-13-week view for 21 weeks. — as of 5 August 2026.

What were Uranium Royalty Corp.'s latest quarterly results?

Uranium Royalty Corp. reported revenue of $0.0 B and net profit of $0.0 B for the Jan 26 quarter. Earnings per share were $0.01. The operating margin was 0.0%. — as of 5 August 2026.

What is Uranium Royalty Corp.'s revenue?

Uranium Royalty Corp. reported revenue of $0.0 B in the Jan 26 quarter. For the full FY25 fiscal year, revenue was $0.0 B (−50.0%). Over the last 2 years revenue compounded at 41.4% a year. — as of 5 August 2026.

What is Uranium Royalty Corp.'s profit?

Uranium Royalty Corp. earned $0.0 B of net profit in the Jan 26 quarter. Full-year FY25 profit was $−0.0 B. The operating margin ran 0.0% in the latest quarter. — as of 5 August 2026.

What is Uranium Royalty Corp.'s market cap?

Uranium Royalty Corp.'s market capitalisation is $1.0 B at a stock price of $3.4. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.

Does Uranium Royalty Corp. pay a dividend?

No — Uranium Royalty Corp. has declared no dividend per share in any of its last 10 reported quarters, so there is no payout history and no yield to quote. That is a reading of the filed statements, not an estimate. — as of 5 August 2026.

How is Uranium Royalty Corp. performing?

Uranium Royalty Corp.'s latest readings are below. Against the S&P 500 it has been behind on a trailing-13-week view for 21 weeks. This describes what the data did, not a rating. — as of 5 August 2026.

Is Uranium Royalty Corp. beating the market?

Not lately — on a trailing-13-week view Uranium Royalty Corp. is currently behind the S&P 500 (21 weeks and counting; last ahead the week of 2026-03-13), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 1.1 years the stock moved +41% against the S&P 500's +24% — ahead of the index over the full window. — as of 5 August 2026.

Will Uranium Royalty Corp.'s stock price go up?

This page publishes no price forecast for Uranium Royalty Corp. What it measures instead: the stock price is $3.4. Direction is not something this site claims to know. — as of 5 August 2026.

Is the market betting against Uranium Royalty Corp.?

No — short interest is 0.9% of Uranium Royalty Corp.'s tradable float, about 1.5 days to cover at typical volumes. That is a low reading: the crowd is not positioned against this stock. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 5 August 2026.

What is Uranium Royalty Corp.'s cash flow?

Uranium Royalty Corp. generated $−0.0 B of operating cash flow in FY25. Reported profit that year was $−0.0 B, so operating cash ran behind profit. — as of 5 August 2026.

How financially safe is Uranium Royalty Corp.?

On the balance sheet, the Z-score reads 6.68 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That sits well clear of trouble. — as of 5 August 2026.

Where is Uranium Royalty Corp. in its business cycle?

Uranium Royalty Corp.'s FY25 operating margin was 0.0%, against a 3-year band of 0.0%–25.0%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran 0.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.

What could break the Uranium Royalty Corp. story?

The sharpest disagreement: the price moved +33.5% in a year while annual EPS moved −150.0% — the difference is re-rating, and re-rating has to be repaid with earnings. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.

Is Uranium Royalty Corp. a stock worth studying right now?

This is not investment advice. The machine read: Uranium Royalty Corp.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: whether earnings grow into a price that has already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI